Mounjaro Chronic Weight Management Launch Event – Unveiling the first GIP and GLP-1 RA anti-obesity medication

Introduction

Learn about the obesity as a chronic disease, the role of GIP and GLP-1 in obesity and the mechanism of action of Mounjaro as first-in-class medication for chronic weight management.

Objectives

-Learn about obesity as a chronic disease which is a public health issue across the globe and specially in KSA.
-Better understanding of the Pathophysiology of obesity, the related metabolic adaption and the role of GIP and GLP-1 receptors.
-Unveiling the mechanism of action of Mounjaro as the first-and-only treatment activating both the GIP and GLP-1 receptors to treat chronic weigh management.
-Understand the data from the clinical trials related to efficacy and safety of Mounjaro.

This Course For :

Physician ( Endocrinology & Metabolism , Family Medicine , Internal Medicine , General Practitioners )
Resident / Fellow ( Endocrinology & Metabolism , Family Medicine , Internal Medicine , General Practitioners )

Speaker

Price

Course Fee

FREE

FREE
See Registration Policies, Cancellations & Refunds

Contact Information

Organization : Virtual Medical Academy
Phone : 920008161
Email : [email protected]

  • 08 Mar 2024    To    08 Mar 2024
  • 02:30 PM  To  05:30 PM
  • Certificate Available
  • Online Click Here
  • 505
  Add to Calendar 03/08/2024 02:30 PM 03/08/2024 05:30 PM Asia/ Riyadh Mounjaro Chronic Weight Management Launch Event – Unveiling the first GIP and GLP-1 RA anti-obesity medication Mounjaro Chronic Weight Management Launch Event – Unveiling the first GIP and GLP-1 RA anti-obesity medication https://medicalacademy.org/portal/event/view/2138
Mounjaro Chronic Weight Management Launch Event – Unveiling the first GIP and GLP-1 RA anti-obesity medication